N01199 1380 — Louisville, Kentucky

N01199 1380 is a clinical research site located in Louisville, Kentucky, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

N01199 1380 has participated in 1 clinical trials.

Therapeutic areas: Epilepsy.

Sponsors: UCB PHARMA Inc. (US).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Louisville

Browse all research sites in Kentucky · View every site in Louisville

• University of Louisville Pediatric Sleep Medicine Center
• University of Louisville 501 E. Broadway, Suite 210
• Norton Audubon Hospital-Norton Cancer Institute - Audubon ( Site 0105)
• University of Louisville Ambulatory Internal Medicine Resident Clinic
• University of Louisville Cancer Center
• University Neurologists PSC Pediatric Division
• University of Louisville 550 Clinic
• Norton Cancer Institute, Audubon Hospital Campus
• Kosair Children's Hospital
• (175) University Lousiville
• Department of Pediatric Critical Care, Kosair Children's Hospital
• Kosair Childrens Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for N01199 1380?

N01199 1380 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has N01199 1380 conducted?

N01199 1380 has 1 clinical trials on record. Their work covers Epilepsy.

Is N01199 1380 accredited by Crixeo Clinical Trials?

N01199 1380 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about N01199 1380?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.